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A soluble rat liver nuclear extract containing total RNA polymerase activities also 
exhibits appreciable amounts of protein kinase activity. This unfractionated protein kinase 
catalyzes the phosphorylation of both endogenous proteins and exogenous lysine-rich 
histone in the presence of [y-32P]ATP and Mg’+. The optimal concentration of Mg*+ is 5 
mM for histone phosphorylation and 25 mru for the phosphorylation of endogenous proteins. 
Cyclic AMP has no effect on the phosphorylation of lysine-rich histone by this unfraction- 
ated nuclear protein kinase. However, addition of cyclic AMP causes a reduction in the 3zP- 
labeling of an endogenous protein (CAB which can be characterized by its mobility during 
SDS-acrylamide gel electrophoresis and elution in the unbound fraction of a DEAE- 
Sephadex column. If CA1 is first labeled with 32P and then incubated with 10v6 M cyclic 
AMP under conditions where protein kinase activity is inhibited, the presence of the cyclic 
nucleotide causes a loss of the 32P-labeling of this protein, implying the activation of a 
substrate-specific protein phosphatase. When rat liver RNA polymerases are purified by 
DEAE-Sephadex chromatography, protein kinase activity is found in the unbound fraction 
and in those column fractions containing RNA polymerase I and II. The fractionated 
protein kinases exhibit different responses to cyclic AMP, the unbound protein kinase being 
stimulated and the RNA polymerase-associated protein kinases being dramatically in- 
hibited. A second protein (CAII) whose phosphorylated state is modified by cyclic AMP is 
found within the DEAE-Sephadex column fractions containing RNA polymerase II. The 
cyclic nucleotide in this case appears to reduce labeling of CA11 by inhibition of the protein 
kinase activity which co-chromatographs with both CA11 and RNA polymerase II. Based 
on molecular weight estimates, neither CA1 nor CA11 appears to be an RNA polymerase 
subunit. The identity of CA1 as a protein factor whose phosphorylated state influences 
nuclear RNA synthesis is suggested by the fact that addition of fractions containing CA1 to 
purified RNA polymerase II inhibits the activity of this enzyme, but only if CA1 has been 
previously incubated in the presence of cyclic AMP. 
Models for regulation of transcription 
from eukaryotic chromatin have centered 
around two basic mechanisms. The first of 
these is based upon the knowledge that the 
class of small basic proteins termed his- 
tones serve as inhibitors of transcription (1, 
2). Although as a group they lack tissue and 
species specificity (3), they must be in- 
cluded in any general scheme for nuclear 
genetic regulation, since they are the only 
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major chromatin component shown to 
block transcription. On the other hand, the 
acidic nuclear proteins are heterogeneous 
(4), tissue-specific (5), and confer specificity 
on patterns of nuclear RNA synthesis (6, 
7). These characteristics have led to the 
proposal that positive regulation of tran- 
scription from chromatin exists, based upon 
functional interaction of the acidic nuclear 
proteins with the other nuclear compo- 
nents, for example, RNA polymerase or 
repetitive DNA sequences (8). The struc- 
tural and functional complexity of the nu- 
cleus does not preclude the possibility that 
both modes of regulation may occur simul- 
taneously. 
Complexes between nuclear acidic pro- 
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teins and histones do exist (9, lo), and it is 
possible that this protein-protein interac- 
tion accounts for many of the properties of 
the regulation of RNA synthesis within the 
nucleus. Removal of the general inhibitory 
influence of the histones from chromatin by 
association with specific acidic proteins 
could unmask certain sequences of DNA 
for transcription. Once accomplished, the 
interaction of eukaryotic RNA polymerases 
with protein factors which modify their 
ability to synthesize RNA could constitute 
a secondary site for positive regulation of 
genetic activity. The coordinated regula- 
tion of protein-protein interactions of these 
two types (histone-acidic protein and RNA 
polymerase-protein factors) could provide 
a well-defined, stringent system to ensure 
the unique transcription of particular chro- 
matin sites. 
If so, some process must exist for altering 
the functional association of these proteins, 
Phosphorylation of nuclear proteins, pri- 
marily the nonhistones, correlates well with 
genetic activity (l&12). Within the last few 
years, the involvement of nuclear protein 
phosphorylation as a factor in regulation 
has been seen to be increasingly complex. 
One aspect of this complexity is that cyclic 
AMP functions within the nucleus in a va- 
riety of ways to influence the state of nu- 
clear protein phosphorylation. On the one 
hand, this nucleotide stimulates the phos- 
phorylation of lysine-rich histone, presum- 
ably opening up new sites for transcription 
(13). In addition, cyclic AMP has also been 
shown to affect the phosphorylated state of 
the nonhistone proteins both in a positive 
and a negative manner (14-16). In most 
cases, it remains to be demonstrated clearly 
that these cyclic AMP-induced changes in 
phosphorylation are linked in a causal man- 
ner to the interaction, and hence, to the 
function of the nuclear proteins. 
The present studies demonstrate the 
presence of protein kinase and protein 
phosphatase activity in a rat liver nuclear 
extract containing RNA polymerase activ- 
ities. While studying the effects of cyclic 
AMP on these enzymes and upon the phos- 
phorylated state of nuclear phosphopro- 
teins, we have found that cyclic AMP 
causes: 1) inhibition of the protein kinases 
which co-chromatograph with both forms 
of RNA polymerase on a DEAE-Sephadex 
column and stimulation of a protein kinase 
which separates from these enzymes in the 
unbound fraction from this column, and 2) 
activation of a nuclear protein phosphatase 
which reduces the phosphorylation of a spe- 
cific no&&one protein (CAR, That CA1 
may function within the nucleus as a regu- 
lator of RNA polymerase activity is sug- 
gested by the fact that following preincu- 
bation with cyclic AMP, CA1 is able to 
inhibit the activity of RNA polymerase II. 
Preliminary reports of this work have 
already appeared (4, 17). This work sug- 
gests that cyclic AMP can influence the 
phosphorylation of nuclear proteins in such 
a manner as to modify the functional inter- 
actions of such proteins with other nuclear 
components, possibly including RNA po- 
lymerase. 
MATERIALS AND METHODS 
Preparation of a soluble rat liver nuclear extract. 
The procedure was the method of Roeder and Rutter 
for the preparation of liver RNA polymerases (18). 
For each preparation, 25 g of rat liver were homoge- 
nized in 2 volumes of 0.34 M sucrose, 15 mM magnesium 
acetate, 0.25 mM spermine. The homogenate was di- 
luted with 2 volumes of 2.3 M sucrose; 2%ml portions 
were placed in centrifuge tubes and underlayered with 
10 ml of 2.3 M sucrose. After centrifugation at 105,000 
g for 1 l-n, the nuclear pellets were suspended in 50 ml 
of 0.01 M Tris-HCl, pH 7.9, 1.0 M sucrose, 5 mM MgClz, 
5 mM dithiothreitol. Ammonium sulfate (4 M) was 
added to a final concentration of 0.3 M and the viscous 
solution stirred for 10 min. 
The preparation was sonicated in 25-ml fractions 
for 10 s at setting 75 on a Biosonic sonicator (Bronwill) 
equipped with a microtip. The sonication was repeated 
5 times with a 30-s pause between each sonication. 
Two volumes of 0.05 M Tris-HCl, pH 7.9,25% glycerol, 
5 mM MgClz, 0.1 mM EDTA, 0.5 mM dithiothreitol 
were added. After mixing, the solution was centrifuged 
for 1 h at 105,000 g. Solid ammonium sulfate was 
added to the supematent over a period of 30 min and 
the solution stirred at 4°C for an additional 40 min. 
After centrifugation at 105,000 g for 1 h, the protein 
pellets were suspended in TGMED3 and dialyzed 
against TGMED, 0.05 M ammonium sulfate for 4-6 h. 
The pellets resulting from a centrifugation at 105,000 
g for 1 h were discarded and the supematent assayed 
3 Abbreviations used: TGMED, 0.05 M Tris-HCl, 
pH 7.9, 25% glycerol, 5 mru MgC12,0.1 mru EDTA, and 
0.5 mM dithiothreitol; TCA, trichloroacetic acid; SDS, 
sodium dodecyl sulfate; CA1 and CAII, cyclic AMP- 
influenced protein I and protein II. 
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for RNA polymerase activity. The enzyme was stored 
at -76’C in TGMED, 0.05 M ammonium sulfate. 
Assay of RNA polymerase activity. The assay for 
RNA polymerase activity contained the following in a 
final reaction volume of 0.75 ml: 60 mM Tris-HCl, pH 
8.0, 3 mu NaF, 20 mu MgCh, 3 mbr spermine, 0.4 M 
ATP, CTP, and GTP, 100 pg of calf thymus DNA in 
0.1~ SSC (0.015 M NaCl, 0.0015 M sodium citrate) and 
1 pCi[3H]UTP (specific activity, 20 gCi/mmol). Cyclic 
AMP was added in various concentrations as given in 
individual experiments. Reactions were begun with 
the addition of enzyme. After 4 min of incubation at 
37”C, 4 M ammonium sulfate was added to a final 
concentration of 60 mM and the incubation continued 
for 16 min. Reactions were terminated by the addition 
of 5 ml of 5% trichloroacetic acid, sodium pyrophos- 
phate. The solutions were passed through nitrocelIu- 
lose fdters (presoaked in 1 mM ATP). The filters were 
washed 2 times with 5 ml of 5% TCA, 1% sodium 
pyrophosphate, dried, and counted for radioactivity in 
5 ml of toluene-based scintillation fluid (4 g Omni- 
fluor/l g toluene). 
Assay of protein kinase activity. A standard assay 
volume of 0.5 ml contained 50 mM Tris-HCl, pH 7.4, 
25 mM MgClz, 1 &i[y-32P]ATP (specific activity, 16 
Ci/mmob final concentration, 1.3 x 10e7 M) and the 
reactions begun with the addition of enzyme. To mea- 
sure the magnesium dependence of the reaction, the 
final concentration of this cation was varied from 5 to 
50 mM. Where added, the concentration of EDTA was 
50 mu. Cyclic AMP was added to some assays in the 
concentrations given in individual experiments For 
measurement of histone phosphorylation, 100 pg of 
lysine-rich histone were added. After 10 min at 37”C, 
3 ml of 1 mM ATP were added, followed by 3 ml of 
10% TCA, 2% sodium pyrophosphate. The samples 
were filtered through nitrocellulose filters, dried, and 
counted for 32P in toluene-based scintillation fluid. For 
precipitation of histone reaction mixtures, 0.092 M 
silicotungstic acid was added to the 10% TCA, 2% 
sodium pyrophosphate solution. 
Protein phosphatase assays. The effect of cyclic 
AMP on protein phosphatase activity in the soluble 
nuclear preparation was measured by prephosphory- 
lating these proteins with [Y-~*P]ATP under standard 
conditions, followed by the addition of EDTA to the 
assays to a final concentration of 50 mu. These sam- 
ples were then incubated for an additional 20 mm in 
the presence or absence of cyclic AMP. These samples 
were then routinely prepared for electrophoresis, as 
described below, on 5% SDS-acrylamide gels. 
Electrophoresis of phosphorylated proteins. Pro- 
tein kinase or protein phosphatase assays were ter- 
minated by the addition of solid urea to a final con- 
centration of 4 M. The samples were dialyzed against 
1 liter of 0.01 M sodium phosphate, pH 7.0, 0.01% 2- 
mercaptoethanol-0.1% SDS (dialysis buffer) at room 
temperature overnight. The samples were then con- 
centrated by dehydration using Bio-gel P-200 and 
redialyzed. Protein concentration was determined by 
the method of Lowry (19). Electrophoresis was by the 
method of Weber and Osbom (20), using 5% gels. After 
loading of the gels with protein samples, the gels were 
run for 4 h at 8 mA per gel. Gels were stained in 0.25% 
Coomassie blue. After destaining electrophoretically 
at 200 mA for 2 h, gels were scanned at 400 nm in a 
Gilford spectrophotometer equipped with a linear gel 
transport device or were sliced at l-mm intervals and 
the individual slices counted for “P. 
Purification of RNA polymerases and associated 
proteins by DEAE-Sephadex chromatography. The 
DEAE-Sephadex used in the column purification was 
prepared as follows: 10 g of DEAE-Sephadex (A-25) 
was swollen overnight in 30 volumes of distilled Hz0 
(pH 8.0 with 2 M Tris). The swollen gel was washed 
two times with 30 volumes (v/v) 0.5 M ammonium 
sulfate (pH 8.0) and three times with 30 volumes (w/v) 
of the same ammonium sulfate solution. The final 
washed gel was stored as a suspension in TGMED, 
0.05 M ammonium sulfate at 4°C. Columns of 0.8 X 12 
cm were poured and equilibrated under pressure (flow 
rate, 1 ml per min) with 5 bed-volumes of TGMED, 
0.05 M ammonium sulfate. Enzyme preparations were 
applied to the column at this flow rate and the column 
washed with TGMED, 0.05 M ammonium sulfate until 
30 l-ml fractions had been collected. At this point, a 
50-ml linear ammonium sulfate gradient (0.05 to 0.5 M 
ammonium sulfate in TGMED) was started and l-ml 
fractions collected. 
For RNA polymerase assays, 200 to 500 ).d of each 
fraction was employed in the standard RNA polym- 
erase assay described above, except that no additional 
ammonium sulfate was added to each fraction. Protein 
kinase assays, as outlined previously, contained 100 
~1 of each column fraction; endogenous protein served 
as the source of protein kinase activity, as well as 
substrate in these cases. 
Separation of phosphorylated proteins. Column 
fractionation of phosphorylated proteins was per- 
formed after proteins had been labeled with [Y-~‘P] 
ATP in the standard protein kinase assay in the pres- 
ence or absence of cyclic AMP. Ten identical assays of 
each type were combined and dialyzed overnight 
against 1 liter TGMED, 0.05 M ammonium sulfate at 
4°C. The protein was applied to a prepared DEAE- 
Sephadex column, which was then washed with 30 ml 
of TGMED, 0.05 M ammonium sulfate, followed by 
elution of RNA polymerases and associated proteins 
with a linear gradient (0.05 to 0.5 M ammonium sulfate 
in TGMED). One-tenth milliliter of each fraction was 
precipitated with 5 ml 5% TCA, 1% sodium pyrophos- 
phate and filtered through nitrocellulose filters and 
washed two times with 5 ml of the same solution. 
These filters were then dried and counted in toluene- 
based scintillation fluid. Column fractions containing 
peaks of radioactivity were combined and dialyzed 
against SDS dialysis buffer overnight. They were then 
concentrated with Bio-gel P-200 and redialyzed prior 
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to electrophoresis on 5% SDS-acrylamide gels by the 
method of Weber and Osbom (20). 
RESULTS 
Characterization of the Protein Kinase 
Activity Associated with a Soluble Rat 
Liver Nuclear Preparation 
A soluble preparation from rat liver nu- 
clei, prior to chromatography on DEAE- 
Sephadex, contains appreciable amounts of 
protein kinase. This unfractionated protein 
kinase activity catalyzes the phosphoryla- 
tion of endogenous proteins in the presence 
of [Y-~~P]ATP and Mg2+. A minimum of 
80% of the 32P-labeling of the proteins 
within a nuclear extract of this type can be 
accounted for by [32P]phosphoserine (21). 
This nuclear protein kinase fraction can 
also phosphorylate exogenous lysine-rich 
histone. The magnitude of phosphorylation 
which occurs when exogenous histone is 
added to the soluble nuclear preparation is 
no greater than that seen with endogenous 
proteins alone (Fig. 1). SDS gel electropho- 
retie analysis shows that under the former 
conditions, it is the histones which are 
phosphorylated, while the incorporation of 
[Y-~~P]ATP into the higher molecular 
weight endogenous proteins is suppressed. 
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This suggests a possible interaction be- 
tween these proteins which can influence 
the ability of some nuclear nonhistone pro- 
teins to be phosphorylated. 
Although the phosphorylation of both 
endogenous proteins and lysine-rich his- 
tone are dependent upon the presence of 
Mg2+, the optimal concentration of the cat- 
ion differs for each substrate. Histones are 
maximally phosphorylated at approxi- 
mately 5 mM MF, while endogenous pro- 
tein phosphorylation by this nuclear pro- 
tein kinase fraction is supported optimally 
at a Me concentration of 25 mu (Fig. 1). 
Although the possibility that the ion con- 
centration is affecting the substrates differ- 
ently cannot be excluded, these Mg2+ con- 
centration curves suggest the presence of at 
least two distinct protein kinases within the 
soluble nuclear preparations. 
Effects of Cyclic AMP on the Phosphoryl- 
ation of Histones and of Endogenous 
Proteins Within the Soluble Nuclear 
Preparations from Rat Liver 
Cyclic AMP, at concentrations from 10e5 
to lo-’ M, has no apparent effect on the 
total phosphorylation of either exogenous 
histones or of endogenous proteins by the 
6. 
5 50 
OF Mg++- mM 
FIG. 1. Magnesium dependence of the protein kinases present in a soluble rat liver nuclear 
preparation. Rat liver RNA polymerases were prepared by the method of Roeder and Rutter, up 
to the DEAE-Sephadex chromatography step (18). Aliquots were incubated as described in 
Materials and Methods for protein kinase activity, except that the magnesium concentration was 
varied and 100 pg of lysine-rich histone were added to some assays. In each case, the reaction 
volume contained 200 pg of enzyme protein. Magnesium dependence of protein kinase without 
exogenous substrate, M; magnesium dependence of protein kinase in the presence of lysine- 
rich histone, w. 
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nuclear protein kinase fraction described 
above (data not shown). Moreover, electro- 
phoresis of lysine-rich histone phosphoryl- 
ated by this source of nuclear protein kinase 
shows no detectable differences in the la- 
beling of any individual components of the 
lysine-rich histone. This lack of response to 
cyclic AMP is not due to substrate activa- 
tion of the protein kinase during the time 
required to set up the assay, as has been 
reported by Miyamoto, et al. (22), since no 
effect on phosphorylation of histones is 
seen regardless of whether the protein ki- 
nase reactions were started by addition of 
labeled ATP or histone (data not shown). 
Addition of cyclic AMP to the total sol- 
uble nuclear preparation does cause a dra- 
matic reduction in the phosphorylation of 
a specific Coommasie Blue-staining band, 
which, because of its migratory behavior 
(and hence, size) on SDS-acrylamide gels, 
is a no&i&one. Loss of the 32P-labeling of 
the peak of radioactivity appears to be de- 
pendent upon the concentration of cyclic 
AMP in the phosphorylation medium. To- 
tal loss of a specific peak of radioactivity on 
5% SDS-acrylamide gels is seen in the pres- 
ence of concentrations of cyclic AMP from 
10m6 M up to 10e3 M (Fig. 2, A through E). 
However, 32P-labeling of proteins in the 
presence of lo-’ and 10e8 M cyclic AMP 
resembles the control situation, although 
some reduction in the 32P-labeling of this 
protein band may still be apparent (Fig. 2, 
A, F, and G). To determine whether the 
decreased 32P-labeling seen in the presence 
of cyclic AMP is caused by inhibition of 
protein kinase activity, experiments were 
performed in which soluble nuclear prepa- 
rations were prelabeled with [Y-~~P]ATP. 
After prelabeling, incubation was continued 
for an additional 20 min in the presence of 
50 m EDTA f lo+ M cyclic AMP. (Ad- 
dition of this concentration of EDTA com- 
pletely inhibits protein kinase activity, as 
shown in Fig. 3A). 
The 32P-labeling of the soluble nuclear 
fraction remains indistinguishable from 
control samples, as shown by the solid line 
in Fig. 3A, after further incubation with 
EDTA alone. However, since a selective 
loss of 32P-labeling from a specific protein 
band on SDS gels is seen in the presence of 
DISTANCE OF MIGRATION hm) 
FIG. 2. Effect of cyclic AMP on the phosphorylation 
of proteins associated with a soluble rat liver nuclear 
preparation. Standard protein kiuase assays were per- 
formed with the indicated concentrations of cyclic 
AMP. Reactions were stopped by the addition of solid 
urea to a final concentration of 4 M. Samples were 
dialyzed, concentrated, and run on 5% SDS-acrylam- 
ide gels. Gels were sliced, dried, and counted in tolu- 
ene-based scintihation fluid for 32P. A, control; B, 10m3 
M cyclic AMP; c, lo-’ M cyclic AMP; D, lo-’ M cyclic 
AMP, E, 1O-6 M cyclic AMP; F, lo-’ M cyclic AMP; G, 
lo-’ M cyclic AMP. 
50 lll~ EDTA and 10m6 M cyclic AMP (Fig. 
3B), we conclude that cyclic AMP activates 
a nuclear protein phosphatase, possessing 
substrate specificity. 
Fractionation of Phosphorylated Proteins 
on DEAE-Sephadex 
In order to obtain a more defined char- 
acterization of the protein component de- 
phosphorylated in response to cyclic AMP, 
the soluble nuclear preparations were pre- 
phosphorylated and the endogenous pro- 
teins were separated by DEAE-Sephadex 
chromatography, employing a 0.05 to 0.5 M 
ammonium sulfate gradient. After fraction- 
ation, phosphorylated proteins appeared in 
the unbound fraction of the column and 
were eluted from those regions of the gra- 
dient with RNA polymerase activity (Fig. 
4). When column fractions were analyxed 
on 5% SDS-acrylamide gels, specific pat- 
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terns of protein phosphorylation were 
found in the unbound fraction and in those 
fractions containing both RNA polymerase 
I and II (Fig. 5, A, C, and E). 
The addition of low6 M cyclic AMP to the 
prephosphorylation medium causes no 
change in the overall distribution of phos- 
phorylated proteins following DEAE-Seph- 
adex chromatography, but does cause a 
marked inhibition of 32P-labeling of one 
protein component of the unbound fraction 
(Fig. 5B). Based on its electrophoretic mo- 
bility, we assume that the single peak which 
is less phosphorylated in response to cyclic 
AMP in the unbound column fraction cor- 
responds, at least in part, to the component 
dephosphorylated by the cyclic nucleotide 
in the whole nuclear soluble fraction (com- 
FIG. 3. Effect of cyclic AMP on the protein phos- 
phatase activity associated with a soluble rat liver 
nuclear preparation. A, standard protein kinase assays 
were performed as described in Fig. 2, in the presence 
or absence of 50 mM EDTA. O-----O, control protein 
kinase activity; G----O, protein kinase activity in the 
presence of 50 mM EDTA. B, standard protein kinase 
assays were performed. After a lo-min incubation, 50 
mM EDTA + 10e6 M cyclic AMP were added and the 
samples incubated for a further 20 min. Samples were 
then analyzed by gel electrophoresis as described in 
Materials and Methods. 
pare Fig. 3A with Fig. 5A). Changes in the 
phosphorylation pattern of the proteins in 
the RNA polymerase I column fractions are 
also seen in the presence of 10e6 M cyclic 
AMP (Fig. 5D), although the absolute 
changes in the peaks of radioactivity rela- 
tive to one another have not yet been de- 
termined. 
The presence of a single, phosphorylated 
protein in RNA polymerase II column frac- 
tions (Fig. 5E) makes determination of the 
effect of cyclic AMP on its labeling difficult. 
However, as shown by data in the following 
section, cyclic AMP inhibits the protein 
kinase activity associated with RNA po- 
lymerase II on a DEAE-Sephadex column, 
using endogenous proteins as substrates. 
Since electrophoretic analysis demon- 
strates only a single phosphorylated protein 
within this fraction, it follows logically that 
cyclic AMP must be causing reduction in 
the 32P-labeling of this protein. 
To ease description of the data, we have 
devised a nomenclature for the phospho- 
rylated proteins derived by fractionation of 
the soluble rat liver preparation on DEAE- 
Sephadex. The protein component found in 
the unbound fraction is termed cyclic 
AMP-influenced protein I, or simply, CAI. 
The single, phosphorylated protein co- 
chromatographing with RNA polymerase 
II is called cyclic AMP-influenced protein 
II (CAII). These proteins are designated as 
such in Fig. 5, B and F. 
Molecular Weight Estimates of CAI and 
CAII 
Molecular weights of CA1 and CA11 were 
estimated by comparison to proteins of 
known molecular weights derived from red 
blood cell membranes (23). Samples run on 
5% SDS-acrylamide gels indicate the size of 
protein CA1 to be 28,000 and of protein 
CA11 to be 52,060. The reported molecular 
weights of 197,000, 126,000, 51,000, 44,000, 
25,000 and 16,500 for the subunits of liver 
RNA polymerase I (24) and 220,600, 
214,000, 180,000, 165,000, 140,000, 34,000, 
25,000, and 16,500 for a mixture of the sub- 
units of the two forms of liver RNA polym- 
erase II (25) suggest that CA1 and CA11 are 
not RNA polymerase subunits (Fig. 6). This 
is further suggested in the case of CA1 by 
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FIG. 4. Fractionation of 32P-labeled soluble nuclear preparation from rat liver on DEAE- 
Sephadex. Proteins were prelabeled in a standard protein kinase reaction, dialyzed against 
TGMED, 0.05 M ammonium sulfate at 4”C,and chromatographed as described in Materials and 
Methods. An aliquot of each column fraction was assayed for RNA polymerase activity and 
counted for 32P in toluene-based scintillation fluid. 
the fact that this protein separates from the 
RNA polymerases on DEAE-Sephadex. 
Effects of Cyclic AMP on Protein Kinase 
Activities Associated with DEAE-Seph- 
adex Column Fractions 
After chromatography of the soluble 
preparation from rat liver nuclei on DEAE- 
Sephadex, protein kinase activity is found 
associated with the unbound fraction and 
also in those fractions possessing RNA po- 
lymerase I and II activities. Moreover, 
these protein kinases demonstrate mark- 
edly different responses to 10m6 M cyclic 
AMP. The protein kinase in the unbound 
fraction is stimulated by the cyclic nucleo- 
tide, whereas protein kinase activities co- 
chromatographing with RNA polymerase I 
and II are dramatically inhibited by the 
same concentration of cyclic AMP (Table 
I). It should be noted that the DEAE-Seph- 
adex fractions served as the source of both 
protein kinase and substrate for the phos- 
phorylation. 
The possibility exists that the action of 
cyclic AMP on RNA polymerase I and II 
column fractions is the activation of endog- 
enous protein phosphatases, rather than 
the inhibition of protein kinase activities 
within these fractions. We find this un- 
likely, however, because we find no signifi- 
cant protein phosphatase activity associ- 
ated with RNA polymerase I or II frac- 
tions, using ““P-labeled nuclear phospho- 
proteins as substrates, in either the pres- 
ence or absence of low6 M cyclic AMP. 
Under these conditions, protein phospha- 
tase activity is found only in the unbound 
fraction following DEAE-Sephadex chro- 
matography. A slight stimulation (approxi- 
mately 20%) of this enzyme activity is seen 
in response to 10m6 M cyclic AMP. This 
small degree of cyclic AMP-dependent ac- 
tivation may reflect the use of an exoge- 
nous, heterogeneous substrate. Alternately, 
DEAE-Sephadex chromatography may 
cause a separation of this protein phospha- 
tase activity from a regulatory factor which 
normally confers a cyclic AMP-dependence 
upon this enzyme. 
Reconstitution of DEAE-Sephadex Un- 
bound Fraction and RNA Polymerase 
II Column Fractions 
Factors influencing the activity of eukar- 
yotic RNA polymerases have been de- 
scribed (26, 27) and some indications exist 
that these may be phosphorylated proteins 
(28,29). Therefore, we sought to determine 
whether the phosphorylated proteins we 
have identified could modify the activity of 
RNA polymerase. 
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Frc. 5. Effect of cyclic AMP on the labeling of proteins associated with rat liver RNA polymerase 
after DEAE-Sephadex chromatography. Soluble rat liver nuclear preparations were prephosphor- 
ylated in a standard protein kinase reaction t 10e6 M cyclic AMP as described in Materials and 
Methods and fractionated on a DEAE-Sephadex column. In each case, the peaks of 32P-labeled 
material were collected as indicated by the bracketed areas in Fig. 4 and termed the unbound 
fraction (A), RNA polymerase I (B), and RNA polymerase II (C) fractions, Each was analyzed on 
5% SDS-acrylamide gels. A, control-unbound fraction; B, cyclic AMP-unbound fraction; C, control- 
RNA polymerase I fraction; D, cyclic AMP-RNA polymerase I fraction; E, control-RNA poly- 
merase II fraction; F, cyclic AMP-RNA polymer- II fraction. 
20 21%240,000 h TABLE II EFFECT OF CA1 ON THE Ac~rwm OF PURIFIED RNA 
POLYMERASE II FROM RAT LIVER 




RNA polymerase II 2152 
RNA polymerase II + CA1 2430 
RNA polymerase II + CA1 (preincu- 367 
bated with 10m6~ cyclic AMP) 
I \ 
10 23 30 40 50 60 ’ CA1 (100 pg), purified by DEAE-Sephadex chro- 
MOSIUTY (mm) matography after preincubation in the presence or 
*FIG. 6. Determination of the molecular weight of absence of 10m6~ cyclic AMP, was added to 200 ,ug of 
CA1 and CA11 by SDS acrylamide electrophoresis. column-purified RNA polymerase II. RNA polymer- 
Proteins of known molecular weight, derived from red ase activity was determined by the standard reaction. 
blood cell membranes, were used as markers for the 
estimation of the molecular weights given in the figure. rified RNA polymerase II preparations. 
Marker proteins, CA1 and CA11 were run on 5% SDS- Table II demonstrates that CAI, preincu- 
acrylamide gels as described in Materials and Meth- bated in the absence of cyclic AMP, has no 
effect on RNA polymerase II activity. How- 
TABLE I ever, if CA1 is purified after preincubation 
EFFECT OF CYCLIC AMP ON PROTEIN KINASE 
with 10e6 M cyclic AMP and then added to 
ACTIVITIES ASSOCIATED WITH RAT LIVER RNA RNA polymerase II, it has acquired the 
POLYMERASE COLUMN FRACTIONS~ ability to inhibit RNA synthesis. Since the 
Column fraction Protein kinase dephosphorylation of CA1 is the only ap- 
activity 
(32P cpm) 
parent effect of cyclic AMP on the compo- 
nents of the unbound column fraction, it is 
Unbound fraction, control 280 assumed that it is this modification which 
Unbound fraction, cyclic AMP 1325 is correlated with the ability of this column 
RNA polymerase I, control 928 fraction to inhibit the activity of RNA po- 
RNA polymerase I, cyclic AMP 88 lymerase II. 
RNA polymerase II, control 961 
RNA nolvmerase II. cvclic AMP 153 DISCUSSION 
LI Rat liver RNA polymerases were fractionated on Information accumulating on the in- 
a DEAE-Sephadex column and the unbound fraction, volvement of cyclic AMP in the regulation 
RNA polymerase I and II fractions collected. Endog- of nuclear function demonstrates that this 
enous protein kinase activity of these fractions was 
measured in a standard protein kinase assay in the 
nucleotide can act in a variety of ways to 
presence or absence of 10m6~ cyclic AMP. Amounts of 
modify the phosphorylated state of certain 
protein in the protein kinase assays equal 50 pg for the 
nuclear proteins. Our work reinforces these 
unbound and RNA polymerase I fractions and 160 pg observations and provides the added infor- 
for the RNA polymerase II fractions. mation that cyclic AMP-induced modifica- 
tions of nuclear protein phosphorylation 
As one approach, the following recombi- may result from alterations in the activity 
nation experiments were performed. Solu- of both phosphoprotein kinases and phos- 
ble rat liver nuclear preparations were pre- phatases. More specifically, we have dem- 
phosphorylated with unlabeled ATP in the onstrated, in a system derived from rat liver 
presence or absence of 10m6 M cyclic AMP. nuclei, that cyclic AMP can 1) inhibit those 
These reaction volumes were dialyzed over- forms of nuclear protein kinase which co- 
night against TGMED, 0.05 M ammonium chromatograph on DEAE-Sephadex with 
sulfate, and in each case, the CAI-contain- both RNA polymerase I and II; 2) stimulate 
ing fraction was purified by DEAE-Sepha- the protein kinase which separates from 
dex chromatography. These CA1 fractions these RNA polymerases on the same col- 
were then added separately to column-pu- 
. _ 
umn; and 3) activate a nuclear protein phos- 
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phatase with apparent substrate specificity. 
In addition, we have identified two specific 
nuclear proteins whose state of phospho- 
rylation appears to be influenced by cyclic 
AMP, suggesting their possible identity as 
functional substrates for the enzymes de- 
scribed above. 
Kish and Kleinsmith (15) have shown 
heterogeniety within the class of nuclear 
protein kinases which phosphorylate non- 
histone proteins, both with regard to sub- 
strate specificity and response to cyclic 
AMP. Our work provides further data with 
regard to these characteristics by analyzing 
nuclear protein kinase and phosphatase ac- 
tivities in association with endogenous sub- 
strates, rather than relying on measure- 
ment of the 32P-labeling of exogenously 
added proteins by these enzymes. Such an 
approach may allow a more functional 
characterization of the phosphorylation of 
specific nuclear proteins. 
DEAE-Sephadex chromatography of rat 
liver RNA polymerases results in a concom- 
mitant separation of several peaks of pro- 
tein kinase activity. Although each peak 
may contain multiple species of protein ki- 
nase, a predominant response to cyclic 
AMP is seen in each case. The unbound 
protein kinase is stimulated by cyclic AMP, 
producing enhanced labeling of endogenous 
protein(s). This enzyme fraction is probably 
identical to that reported by Jungmann and 
Kranias (30). The protein kinase activities 
co-chromatographing with RNA polymer- 
ases I and II are markedly inhibited by the 
cyclic nucleotide, using endogenous pro- 
teins as substrates. The enhanced activity 
of the unbound protein kinase may be an 
example of the classic mechanism of cyclic 
AMP-dependent protein kinase activation. 
However, the means by which this cyclic 
nucleotide inhibits some forms of protein 
kinase activity, such as those described 
here, remains entirely unknown. 
Although a cyclic AMP-dependent pro- 
tein phosphatase has been described for 
membrane preparations (31), our work pro- 
vides the first example of a nuclear protein 
phosphatase which seems to be under the 
regulation of cyclic AMP. Furthermore, 
this particular phosphoprotein phosphatase 
possesses a degree of substrate specificity 
which implies the partial characterization 
of the endogenous substrate for this en- 
zyme, a protein which we have termed CAI. 
The activation of CAI-specific phospha- 
tase by cyclic AMP takes place even when 
protein kinase activity is inhibited by a high 
concentration of EDTA. Under these con- 
ditions, phosphorylation of CAI-phospha- 
tase is eliminated as a mechanism of acti- 
vation. In this regard, CAI-phosphatase re- 
sembles the membrane-bound phosphatase 
described by Maeno et al. (31) in its ability 
to be stimulated by cyclic AMP in the 
absence of protein kinase activity. The pos- 
sibility is not ruled out, however, that cyclic 
AMP stimulates this protein phosphatase 
by dissociating a catalytic activity from an 
inhibitory regulatory component, in a man- 
ner analogous to the situation which exists 
for cyclic AMP-dependent protein kinases. 
Supportive evidence for the idea that 
nuclear protein kinase and protein phos- 
phatase activities may exist in functional 
association within the chromatin already 
exists. Johnson et al. (32) state that the 
catalytic subunit of a cyclic AMP-depen- 
dent nuclear protein kinase from calf thy- 
mus binds directly to DNA, possibly indi- 
cating a means by which sites of phospho- 
rylation are specified within the chromatin. 
Bombik and Baserga (33) have described a 
stimulation of chromatin-bound protein ki- 
nase during proliferation of WI-38 fibro- 
blasts which can be blocked by dibutyryl 
cyclic AMP. A functional complex of pro- 
tein kinase and protein phosphatase has 
been located within synaptosomal mem- 
branes from cerebral cortex (34), and fur- 
ther experimentation may show a similar 
association of enzyme activities within the 
nucleus, providing a mechanism by which 
the phosphorylation of regulatory proteins 
may be reversibly modified. 
On the basis of our findings, we can iden- 
tify two specific nuclear proteins whose 
phosphorylated states appear to be influ- 
enced by cyclic AMP. Both proteins are 
dephosphorylated in response to cyclic 
AMP, but the mechanisms by which cyclic 
AMP causes dephosphorylation of each dif- 
fers. In one case, CAI, dephosphorylation is 
achieved by the activation of a cyclic AMP- 
dependent protein phosphatase, while in 
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the other, CAII, it is achieved by inhibition 
of protein kinase activity. 
After preincubation with cyclic AMP, 
CA1 inhibits RNA polymerase activity 
when added to column-purified RNA po- 
lymerase II. If CA1 has not been preincu- 
bated with cyclic AMP, it has no apparent 
effect on RNA polymerase II activity. Thus, 
since electrophoretic analysis demonstrates 
that cyclic AMP is influencing the phos- 
phorylated state of CAI, we assume it is 
this modification which determines the 
ability of CA1 to alter the activity of RNA 
polymerase II. Although these results are 
of a preliminary nature, the dependence 
upon the dephosphorylated state of CA1 to 
produce inhibition of RNA polymerase II 
suggests some degree of specificity in the 
response. A number of reports in the liter- 
ature discuss the possibility of phosphoryl- 
ation as a regulatory mechanism in deter- 
mining the activity of protein factors asso- 
ciated with RNA polymerase and seem con- 
sistent with our findings. 
For example, Natori et al. (26) have de- 
scribed a nuclear protein factor (SIB which 
interacts with RNA polymerase II. Al- 
though this SII stimulates, rather than in- 
hibits RNA polymerase II activity, it shares 
some characteristics with our CAI. Both 
are found in the unbound fraction of the 
DEAE-Sephadex column used to separate 
RNA polymerases. Moreover, dephospho- 
rylation of both proteins produces negative 
effects on RNA polymerase activity. Incu- 
bation with alkaline phosphatase destroys 
the ability of SII to stimulate RNA polym- 
erase II (28), while dephosphorylation by a 
cyclic AMP-dependent phosphatase ap- 
pears to allow CA1 to inhibit the activity of 
RNA polymerase II. However, the identity 
of dephosphorylated CAT as an “RNA syn- 
thesis factor” requires more detailed anal- 
ysis of the mechanism by which it produces 
inhibition of RNA polymerase II activity. 
Our data also provide some suggestions 
that CA11 may be involved in the regulation 
of RNA polymerase activity. Although not 
a RNA polymerase subunit, it co-chromato- 
graphs with RNA polymerase II on a 
DEAE-Sephadex column, and can be phos- 
phorylated by an endogenous protein ki- 
nase within this fraction. Cyclic AMP 
causes a dephosphorylation of CA11 
through inhibition of this protein kinase. 
Johnson and Hadden (16) have described 
a lymphocyte nuclear acidic protein of iden- 
tical molecular weight (52,000) whose phos- 
phorylation is decreased by agents which 
elevate cellular cyclic AMP levels. Further- 
more, they can correlate these changes with 
inhibition of the incorporation of [3H]uri- 
dine into RNA. Thus, CA11 may be a nu- 
clear protein distributed among a variety of 
tissues and involved in the regulation of 
chromatin RNA synthesis. 
Recent reports have appeared suggesting 
phosphorylation of RNA polymerase itself 
stimulates the activity of this enzyme. Mar- 
telo and Hirsch (35) have phosphorylated 
rat liver RNA polymerase with nuclear pro- 
tein kinase and have shown stimulatory 
effects on enzyme activity. Although cyclic 
AMP, in their system, does stimulate pro- 
tein kinase activity using RNA polymerase 
as substrate, it has little effect on simulta- 
neous RNA synthesis by RNA polymerase 
II. Jungmann et al. (36) have looked at 
RNA polymerase phosphorylation in a 
more homologous system. Using ovarian 
cytosol protein kinase which had been dis- 
sociated to a cyclic AMP-independent form 
to phosphorylate RNA polymerase II from 
the same tissue, they have shown subse- 
quent positive effects on RNA polymerase 
II activity. However, they have not dis- 
missed the possibility that it is the phos- 
phorylation of RNA polymerase-associated 
proteins which are being affected by cyclic 
AMP, and their results could be explained 
by a system of regulation involving the 
interaction of a CAI-type protein with RNA 
polymerase II. Likewise, Dahmus (29) has 
shown that ascites RNA polymerase II ac- 
tivity is stimulated by a protein factor 
(HLFB) which has protein kinase activity. 
Although highly purified RNA polymerase 
II seems to be directly phosphorylated in 
this system, the possibility has not been 
eliminated that it is the phosphorylated 
state of HLFB, or a protein associated with 
either HLF2 or RNA polymerase II which 
is functionally correlated with the stimu- 
lation of RNA polymerase II. 
We wish to suggest that the various ef- 
fects of cyclic AMP within the nucleus on 
protein phosphorylation may be correlated 
to modifications of protein kinase and phos- 
RAT LIVER PHOSPHOPROTEIN 
phatase activities. Whether the resulting 
alterations in protein phosphorylation 
serve a regulatory function in determining 
specific patterns of RNA synthesis in uiuo 
and in vitro is a question deserving of fur- 
ther study. It is worth pointing out in this 
regard that recent evidence suggests that 
phosphorylation of nonhistone proteins se- 
lectively influences the rate of histone gene 
transcription (37), although this effect has 
not yet been linked to changes in cyclic 
AMP. 
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